SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Nortran Pharmaceutical -NRT.V
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Pied Piper who wrote (1148)7/26/1999 4:57:00 PM
From: Pied Piper  Read Replies (1) of 1185
 
I talked with Graham Taylor again today. He gave me a couple of items of interest.

1) Testing the toxicology of the non-narcotic cough drug is going well and should be completed within a week.

2) Nortran is close to a collaboration agreement with Hoechst Marion Roussel, concerning their arrhythmia drug. He couldn't give me an exact date but indicated they are hoping to announce this within the next couple of weeks.

Piper
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News